Stay updated with breaking news from Athersys Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research note published on Friday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Athersys Stock Performance Shares of ATHX stock opened at $0.03 on Friday. Athersys has a fifty-two week low of $0.02 and a fifty-two week high of […]
StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research note issued to investors on Thursday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Athersys Stock Down 3.5 % Shares of Athersys stock opened at $0.03 on Thursday. Athersys has a 52-week low of $0.02 and a […]
StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research note released on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. Athersys Stock Performance Shares of ATHX stock opened at $0.03 on Thursday. The firm has a market capitalization of $1.54 million, a PE ratio of -0.01 […]
/PRNewswire/ -- A latest research report [110+] pages with 360-Degree visibility, titled "Tissue Engineering Market Share, Size, Trends, Industry Analysis...
StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report sent to investors on Monday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Athersys Price Performance ATHX stock opened at $0.02 on Monday. The firm’s fifty day simple moving average is $0.14 and its 200-day simple moving […]